BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7553651)

  • 1. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
    Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
    Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
    Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
    Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of genomic instability in meningioma progression.
    Simon M; Kokkino AJ; Warnick RE; Tew JM; von Deimling A; Menon AG
    Genes Chromosomes Cancer; 1996 Aug; 16(4):265-9. PubMed ID: 8875241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.
    Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J
    Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
    Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
    Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.
    Piaskowski S; Rieske P; Szybka M; Wozniak K; Bednarek A; Płuciennik E; Jaskolski D; Sikorska B; Liberski PP
    Cancer Genet Cytogenet; 2005 Oct; 162(1):63-7. PubMed ID: 16157202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.